{"source": "The New York Times", "lead_paragraph": "The company is facing losing patent protection on drugs that accounted for 74 percent of its sales in 2009.", "keywords": [{"value": "Lilly, Eli, & Co", "rank": "1", "is_major": "N", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "rank": "2", "is_major": "N", "name": "subject"}, {"value": "Inventions and Patents", "rank": "3", "is_major": "N", "name": "subject"}, {"value": "Lechleiter, John C", "rank": "4", "is_major": "N", "name": "persons"}], "multimedia": [], "snippet": "The company is facing losing patent protection on drugs that accounted for 74 percent of its sales in 2009.", "print_page": "1", "blog": [], "headline": {"main": "Patents Ending, Eli Lilly Chases New Drugs", "print_headline": "Bucking the Industry", "sub": "Patents Ending, Lilly Chases New Drugs, Not Acquisitions ;"}, "_id": "541b36ce38f0d8296cb0f42f", "web_url": "http://www.nytimes.com/2010/10/01/business/01lilly.html", "slideshow_credits": null, "byline": {"person": [{"organization": "", "rank": 1, "role": "reported", "lastname": "WILSON", "firstname": "Duff"}], "original": "By DUFF WILSON", "contributor": ""}, "news_desk": "Business", "word_count": "1332", "document_type": "article", "type_of_material": "News", "abstract": null, "pub_date": "2010-10-01T00:00:00Z", "subsection_name": null, "section_name": "Business Day"}